(Q42199421)

English

Impact of defective interfering particles on virus replication and antiviral host response in cell culture-based influenza vaccine production

scientific article published on 19 August 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 October 2017

Impact of defective interfering particles on virus replication and antiviral host response in cell culture-based influenza vaccine production (English)

1 reference

Europe PubMed Central

18 October 2017

influenza vaccine

1 reference

based on heuristic

inferred from title

author name string

Timo Frensing

1

1 reference

Europe PubMed Central

18 October 2017

Antje Pflugmacher

2

1 reference

Europe PubMed Central

18 October 2017

Mandy Bachmann

3

1 reference

Europe PubMed Central

18 October 2017

Britta Peschel

4

1 reference

Europe PubMed Central

18 October 2017

Udo Reichl

5

1 reference

Europe PubMed Central

18 October 2017

language of work or name

0 references

publication date

19 August 2014

1 reference

Europe PubMed Central

18 October 2017

Applied Microbiology and Biotechnology

1 reference

Europe PubMed Central

18 October 2017

98

1 reference

Europe PubMed Central

18 October 2017

8999-9008

1 reference

Europe PubMed Central

18 October 2017

21

1 reference

Europe PubMed Central

18 October 2017

https://scigraph.springernature.com/pub.10.1007/s00253-014-5933-y

0 references

Bioprocess optimization for cell culture based influenza vaccine production

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5933-Y

21 January 2018

Cell-based influenza vaccines: progress to date.

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5933-Y

21 January 2018

Alpha/beta interferons potentiate virus-induced apoptosis through activation of the FADD/Caspase-8 death signaling pathway

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5933-Y

21 January 2018

Preference of RIG-I for short viral RNA molecules in infected cells revealed by next-generation sequencing

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5933-Y

21 January 2018

Gene constellation of influenza A virus reassortants with high growth phenotype prepared as seed candidates for vaccine production

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5933-Y

21 January 2018

Continuous cell lines as a production system for influenza vaccines.

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5933-Y

21 January 2018

The annual production cycle for influenza vaccine.

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5933-Y

21 January 2018

Defective Viral Particles and Viral Disease Processes

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5933-Y

21 January 2018

Productivity, apoptosis, and infection dynamics of influenza A/PR/8 strains and A/PR/8-based reassortants

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5933-Y

21 January 2018

Does the higher order structure of the influenza virus ribonucleoprotein guide sequence rearrangements in influenza viral RNA?

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5933-Y

21 January 2018

Genetic trans-complementation establishes a new model for influenza virus RNA transcription and replication.

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5933-Y

21 January 2018

Monitoring influenza virus content in vaccine production: precise assays for the quantitation of hemagglutination and neuraminidase activity

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5933-Y

21 January 2018

Strand-specific real-time RT-PCR for distinguishing influenza vRNA, cRNA, and mRNA

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5933-Y

21 January 2018

Dynamics of biologically active subpopulations of influenza virus: plaque-forming, noninfectious cell-killing, and defective interfering particles

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5933-Y

21 January 2018

Impact of host cell line adaptation on quasispecies composition and glycosylation of influenza A virus hemagglutinin

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5933-Y

21 January 2018

Infection dynamics and virus-induced apoptosis in cell culture-based influenza vaccine production-Flow cytometry and mathematical modeling

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5933-Y

21 January 2018

Trypsin promotes efficient influenza vaccine production in MDCK cells by interfering with the antiviral host response.

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5933-Y

21 January 2018

Comparison of large-scale mammalian cell culture systems with egg culture for the production of influenza virus A vaccine strains

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5933-Y

21 January 2018

Vaccine manufacturing: challenges and solutions

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5933-Y

21 January 2018

Universal primer set for the full-length amplification of all influenza A viruses

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-5933-Y

21 January 2018

Identifiers

10.1007/S00253-014-5933-Y

1 reference

Europe PubMed Central

18 October 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

18 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42199421&oldid=1935743062"